A difficult feat to accomplish in business is to make dramatic change in the midst of current success. History is littered with companies that were once on top of the […]

Donald Trump is leading in numerous major polls of GOP presidential candidates. And the first Republican presidential debate is looming next week. Whether or not you think Trump’s a spectacle, […]

Amgen Inc. raised its 2015 guidance after reporting that its second-quarter earnings rose 6.9% on better-than-expected sales growth and lower operating expenses. For the year, the biotechnology company now expects […]

By Stefan Armstrong, Partner, AIS, Greater Than One Why “Mid-sized Data” Is Beautiful There was a time—mid-2011 comes to mind—when it seemed that Big Data was poised to turn digital […]

There is creative life outside Manhattan. Yes, really. By Marcia Goddard I had one of those illustrative experiences in the office the other day – you know, when a tiny […]

By Anna Wilde Mathews The Wall Street Journal Biography @annawmathews [email protected] July 29, 2015 6:55 p.m. ET   The leaders of the top five health insurers periodically get together to […]

NEW YORK, NY–(Marketwired – July 30, 2015) – PharmaCyte Biotech (OTCQB: PMCB) is a small international biotechnology firm, but you wouldn’t know it by the company it keeps. How does […]

By Denise Roland The Wall Street Journal Biography @deniseroland [email protected] Updated July 30, 2015 7:51 a.m. ET AstraZeneca PLC on Thursday reported an increase in second-quarter revenue, thanks to proceeds […]

CVS Health (CVS) and IBM (IBM) say they’ve formed a partnership designed to better predict deteriorating health of the pharmacy giant’s customers through predictive analytics. IBM’s Watson, the computer giant’s […]

By Helen Thomas The Wall Street Journal Biography @helenwsj Google+ [email protected] July 29, 2015 11:17 a.m. ET GlaxoSmithKline can yet make a virtue of being boring. The U.K. pharmaceutical group […]